Tuesday, February 11, 2020 11:31:58 AM
Posted by ABMN Staff on Feb 11th, 2020 // No Comments
Bausch Health Companies logoBausch Health Companies (NYSE:BHC) had its target price dropped by investment analysts at Morgan Stanley from $34.00 to $32.00 in a research report issued to clients and investors on Tuesday, BenzingaRatingsTable reports. The brokerage presently has an “overweight” rating on the stock. Morgan Stanley’s target price would suggest a potential upside of 14.78% from the stock’s current price.
A number of other research firms have also recently issued reports on BHC. Barclays restated a “buy” rating and issued a $33.00 price objective on shares of Bausch Health Companies in a research report on Sunday, January 26th. Piper Jaffray Companies boosted their price target on shares of Bausch Health Companies from $30.00 to $39.00 and gave the company an “overweight” rating in a research report on Monday, December 30th. Zacks Investment Research cut shares of Bausch Health Companies from a “buy” rating to a “hold” rating and set a $33.00 price target on the stock. in a research report on Monday, December 16th. HC Wainwright reiterated a “buy” rating and set a $60.00 price target on shares of Bausch Health Companies in a research report on Monday, December 23rd. Finally, TheStreet upgraded shares of Bausch Health Companies from a “d+” rating to a “c” rating in a research report on Thursday, December 12th. Two research analysts have rated the stock with a sell rating, four have given a hold rating and eleven have assigned a buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of $34.06.
BHC stock opened at $27.88 on Tuesday. The firm’s 50-day moving average price is $28.97 and its two-hundred day moving average price is $25.42. Bausch Health Companies has a 12-month low of $18.72 and a 12-month high of $31.97. The stock has a market capitalization of $9.92 billion, a price-to-earnings ratio of -15.84, a PEG ratio of 0.58 and a beta of 1.02. The company has a current ratio of 1.15, a quick ratio of 0.86 and a debt-to-equity ratio of 9.17.
A number of institutional investors and hedge funds have recently made changes to their positions in BHC. Carolina Wealth Advisors LLC bought a new position in Bausch Health Companies during the fourth quarter valued at approximately $31,000. Bessemer Group Inc. raised its position in Bausch Health Companies by 5,071.8% in the fourth quarter. Bessemer Group Inc. now owns 2,017 shares of the company’s stock worth $60,000 after acquiring an additional 1,978 shares during the period. Aigen Investment Management LP bought a new position in Bausch Health Companies in the fourth quarter worth approximately $95,000. Fieldpoint Private Securities LLC bought a new position in Bausch Health Companies in the fourth quarter worth approximately $104,000. Finally, IFP Advisors Inc raised its position in Bausch Health Companies by 2,293.9% in the fourth quarter. IFP Advisors Inc now owns 3,543 shares of the company’s stock worth $105,000 after acquiring an additional 3,395 shares during the period. Institutional investors and hedge funds own 57.38% of the company’s stock.
About Bausch Health Companies
Bausch Health Companies Inc develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through four segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products.
Recommended Story: Most Active Stocks
Analyst Recommendations for Bausch Health Companies (NYSE:BHC)
Successful Trading is the art of minimizing long term risk and maximizing capital allocation.
Recent BHC News
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 09/20/2024 08:05:49 PM
- Meta Strengthens Child Privacy on Instagram; Google Overturns $1.7 Billion Antitrust Fine; Snap Updates Spectacles • IH Market News • 09/18/2024 10:13:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/09/2024 08:54:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/09/2024 08:37:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/06/2024 05:48:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:21:33 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 08/30/2024 10:12:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2024 08:11:10 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 09:39:04 PM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 08/19/2024 09:48:41 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/01/2024 09:27:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2024 08:45:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 11:07:46 AM
- NBA Signs Billion Dollar Broadcast Deal, CrowdStrike Criticized for Insufficient Reward, Honda Shuts Down Chinese Factory • IH Market News • 07/25/2024 10:15:46 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/19/2024 08:34:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/19/2024 11:10:34 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2024 08:12:48 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2024 08:11:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 08:09:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 08:08:33 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM